User Segment Content Display

Potential treatment options and Injectafer savings program

We will send you email updates to continue learning about iron deficiency anemia (IDA) and Injectafer® (ferric carboxymaltose injection), a potential treatment for IDA.

Potential treatment
options for IDA

IDA is serious,but it can be treated. Get more information about oral and IV iron, 2 common IDA
treatment options.

The Injectafer Savings
Program

If you're being treated with Injectafer, the injectafer
Savings Program may be able to help with your
prescription out of pocket responsibility.
*See Terms and Conditons below.

The privacy and security of your personal information is important to Daiichi Sankyo, Inc. The information that you provide us will be shared with
and among our business partners for purposes related to Daiichi Sankyo, Inc., products, programs, services, and market research. Your personal
information will not be used by any of our business partners for their own marketing purposes. By providing your information above, you agree that
Daiichi Sankyo,Inc.,  and our business partners may contact you via email or telephone about our products, programs and services from time to time.
You will be able to cancel your participation at any time by phone or by using the unsubscribe link from emails. For further information about the
Daiichi Sankyo,Inc., privacy policy, please review our Terms Of Use and Privacy Policy.

 

Please Note: At any time, if you decide you no longer wish to receive information by email or telephone, you will be able to unsubscribe.

Terms and Conditions

*TERMS AND CONDITIONS

  1. This offer is valid for commercially-insured as well as cash paying patients.
  2. Depending on insurance coverage, eligible insured patients may pay no more than $50 for Injectafer for the first dose and $0 for Injectafer for the second dose, up to a maximum savings limit of $500 per dose, a $1,000 program limit for coverage up to two doses. Check with your pharmacist or healthcare provider for your copay discount. Patient out-of-pocket expense may vary.
  3. This offer is not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs, or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. Patients may not use this card if they are Medicare-eligible and enrolled in an employer-sponsored health plan or medical or prescription drug benefit program for retirees.
  4. The offer is valid for 1-course, or two doses, of an Injectafer prescription. An explanation of benefits statement must be faxed in prior to transacting on the account numbers for assistance. The account number may be used for additional course of therapy only after re-enrolling. One re-enrollment is allowed per 12-month period
  5. Daiichi Sankyo, Inc. reserves the right to rescind, revoke, or amend this offer without notice.
  6. Offer good only in the USA, including Puerto Rico, at participating pharmacies or healthcare providers.
  7. Void if prohibited by law, taxed, or restricted.
  8. This account number is not transferable. The selling, purchasing, trading, or counterfeiting of this account number is prohibited by law.
  9. This account number is not insurance.
  10. By redeeming this account number, you acknowledge that you are an eligible patient and that you understand and agree to comply with the terms and conditions of this offer.
  11. Qualified patients receiving Injectafer will be allowed a 30-day retroactive enrollment period to receive benefits under the program rules. Any patient wishing to receive this retroactive enrollment assistance must fill out the Eligibility Attestation Form to submit along with the claim from their initial treatment. This form must be completed prior to receiving any copay assistance.

Important Safety Information

Injectafer® (ferric carboxymaltose injection) is available by prescription only. Ask your doctor or healthcare provider if Injectafer is right for you.

What is Injectafer?

Injectafer is a prescription iron replacement medicine administered only by or under the supervision of your healthcare provider. Injectafer is injected into your vein to treat iron deficiency anemia in adults. Injectafer should be used only if you have not responded well to treatment with oral iron, or if you are intolerant to oral iron treatment. It is also used to treat iron deficiency anemia in adults with chronic kidney disease who are not receiving dialysis.

It is not known if Injectafer is safe and effective for use in children.

IMPORTANT SAFETY INFORMATION

Who should not receive Injectafer?

You should not receive Injectafer if you are allergic to ferric carboxymaltose or any of the other ingredients in Injectafer. The active ingredient in Injectafer is ferric carboxymaltose, the inactive ingredients are: water for injection, sodium hydroxide and/or hydrochloric acid.

What should I tell my doctor or healthcare provider before receiving Injectafer?

Before you receive Injectafer, tell your healthcare provider about all of your medical conditions, including if you:

  • Have had an allergic reaction to iron given intravenously (into your vein), including Injectafer, or to other non-oral iron treatments
  • If you have, or have previously experienced, iron overload, or if your body has difficulty using iron appropriately
  • Have high blood pressure
  • Are pregnant or plan to become pregnant. It is not known if Injectafer will harm your unborn baby. Your healthcare provider will decide if it is safe for you to take Injectafer
  • Are breastfeeding or plan to breast feed. Injectafer passes into your breast milk. It is unknown whether Injectafer would pose a risk to your baby. Talk to your healthcare provider about the best way to feed your baby during treatment with Injectafer.

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of Injectafer?

Injectafer can cause serious side effects, including:

  • Serious allergic reactions that may be life-threatening, including shock, low blood pressure, loss of consciousness, and death. Your doctor or healthcare provider will monitor you for signs and symptoms of an allergic reaction during and after each dose of Injectafer for at least 30 minutes. Other serious allergic reactions include itching, rash, hives, wheezing, or low blood pressure. You should report any signs and symptoms of an allergic reaction to Injectafer, in particular rashes, shortness of breath and wheezing to your doctor or healthcare provider.
  • High blood pressure, sometimes with facial flushing, dizziness, or nausea, has been seen during treatment with Injectafer. This increase in blood pressure typically resolves within 30 minutes. Your doctor or healthcare provider will monitor you for signs and symptoms of an increase in blood pressure following each use of Injectafer.

Other serious side effects that have been reported include rash, difficulty breathing, itching, rapid heartbeat, fever, chest discomfort, chills, swelling of the face, lips, or tongue, back pain, muscle aches, and fainting.

The most common side effects of Injectafer include:

  • Nausea, high blood pressure, flushing, low levels of phosphorous in your blood, dizziness, vomiting, headache, an increase in certain liver enzymes, and pain or bruising at the injection site. Potentially long-lasting brown staining of skin near the injection site may occur if Injectafer leaks out of the vein.

Excessive amounts of Injectafer may lead to a condition called iron overload, which is a buildup of iron and may be harmful.

These are not all of the possible side effects of Injectafer.

Tell your doctor if you have any side effect that bothers you or that does not go away. Call your doctor for medical advice about side effects.

General information about Injectafer

Injectafer may impact laboratory tests that measure iron in your blood for 24 hours after receiving Injectafer. Let your healthcare provider and laboratory staff know if you have received Injectafer within 24 hours of having blood tests.

To report side effects, contact American Regent at 1-800-734-9236 or E-mail: pv@luitpold.com or Fax: 1-610-650-0170.

You may also report side effects to the FDA at 1-800-332-1088 or www.fda.gov/medwatch.

The risk information provided here is not comprehensive. To learn more about Injectafer, talk with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at http://www.injectafer.com/pdf/pi.pdf or call 1-800-645-1706.

Please see Full Prescribing Information for Injectafer.